AroCell AB (publ)
STO:AROC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
AroCell AB (publ)
Goodwill
AroCell AB (publ)
Goodwill Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Goodwill | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
AroCell AB (publ)
STO:AROC
|
Goodwill
kr99m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
AddLife AB
STO:ALIF B
|
Goodwill
kr5.4B
|
CAGR 3-Years
1%
|
CAGR 5-Years
38%
|
CAGR 10-Years
N/A
|
|
|
BICO Group AB
STO:BICO
|
Goodwill
kr775.2m
|
CAGR 3-Years
-47%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
|
Biotage AB
STO:BIOT
|
Goodwill
kr2.4B
|
CAGR 3-Years
48%
|
CAGR 5-Years
48%
|
CAGR 10-Years
39%
|
|
|
G
|
Genovis AB
STO:GENO
|
Goodwill
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
MedCap AB (publ)
STO:MCAP
|
Goodwill
kr662.7m
|
CAGR 3-Years
40%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
AroCell AB (publ)
Glance View
AroCell AB is a in vitro diagnostics company, which engages in the monitoring of hematological malignancies, breast cancer, and other solid tumors. The company is headquartered in Uppsala, Uppsala. The company went IPO on 2011-05-25. The firm's principal product candidate, TK-immuno/hem, is a test for monitoring and follow up of blood cancer. The test is based on a patented technology, which have already been evaluated in an early product prototype ELISA method. Apart from that, the Company develops a marker for solid tumor cancer disease. The AroCell cooperates with partners within development, production and sales.
See Also
What is AroCell AB (publ)'s Goodwill?
Goodwill
99m
SEK
Based on the financial report for Dec 31, 2025, AroCell AB (publ)'s Goodwill amounts to 99m SEK.
What is AroCell AB (publ)'s Goodwill growth rate?
Goodwill CAGR 3Y
-11%
Over the last year, the Goodwill growth was 68%. The average annual Goodwill growth rates for AroCell AB (publ) have been -11% over the past three years .
